
Results
25
Most Popular Stocks on the market
25 companies
Celon Pharma
Market Cap: zł1.0b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.
CLN
zł19.60
7D
-0.5%
1Y
-14.8%
Selvita
Market Cap: zł554.3m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł30.00
7D
-0.5%
1Y
-6.0%
Bioceltix
Market Cap: zł509.0m
Engages in the development of stem cell-based biopharmaceuticals for veterinary use.
BCX
zł92.00
7D
3.8%
1Y
-8.9%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł463.2m
A biopharmaceutical company, develops therapeutic molecules for treating oncological and autoimmune diseases in Poland.
CTX
zł72.20
7D
-2.4%
1Y
73.6%
Ryvu Therapeutics
Market Cap: zł360.2m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł15.30
7D
3.4%
1Y
-50.5%
BIOTON
Market Cap: zł329.7m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł3.83
7D
-0.5%
1Y
-8.4%
Synthaverse
Market Cap: zł207.6m
A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.
SVE
zł2.74
7D
-2.7%
1Y
-46.3%
Molecure
Market Cap: zł121.8m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.85
7D
2.6%
1Y
-0.5%
Mabion
Market Cap: zł119.9m
A biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland.
MAB
zł7.46
7D
3.8%
1Y
-23.0%
Poltreg
Market Cap: zł114.8m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł19.30
7D
7.2%
1Y
-40.8%
NanoGroup
Market Cap: zł106.6m
Operates as a biotechnology company in Poland.
NNG
zł2.51
7D
-1.8%
1Y
-5.1%
HyEnergy
Market Cap: zł77.9m
Provides genetic diagnostic solutions in Poland.
HEN
zł2.32
7D
0%
1Y
-34.6%
Urteste
Market Cap: zł73.3m
Engages in the research and development of diagnostic tests for cancers.
URT
zł47.80
7D
2.6%
1Y
-2.4%
Genomtec
Market Cap: zł70.8m
Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
GMT
zł4.70
7D
-2.1%
1Y
-33.6%
Read-Gene
Market Cap: zł54.8m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł4.78
7D
1.9%
1Y
-4.4%
Biogened
Market Cap: zł45.4m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł18.50
7D
1.1%
1Y
-38.3%
Genomed Spólka Akcyjna
Market Cap: zł39.9m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł27.20
7D
-8.1%
1Y
5.4%
Medicofarma Biotech
Market Cap: zł28.7m
Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.
MDB
zł0.42
7D
3.0%
1Y
51.3%
Pure Biologics
Market Cap: zł25.8m
A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.
PUR
zł2.11
7D
0.5%
1Y
-57.3%
genXone
Market Cap: zł20.0m
Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.
GX1
zł5.90
7D
-1.7%
1Y
-1.3%
Stem Cells Spin
Market Cap: zł16.9m
Operates as a biotechnology company in Poland.
SCS
zł0.41
7D
2.0%
1Y
28.1%
Green Zebras Spolka Akcyjna
Market Cap: zł15.5m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł9.45
7D
5.6%
1Y
7.4%
Cannabis Poland
Market Cap: zł13.2m
Operates in the medical cannabis industry in Poland.
CBD
zł0.18
7D
-2.7%
1Y
-44.0%
Tecnovatica
Market Cap: zł5.7m
Does not have significant operations.
TEC
zł0.53
7D
3.1%
1Y
27.7%
Labocanna
Market Cap: zł4.6m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.22
7D
-1.4%
1Y
-27.2%